Skip to content
2000
Volume 21, Issue 2
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Malignant tumors of the head and neck are rare in children, but it is important to know these lesions and identify them early in order to have a good outcome for these patients. Benign lesions of the head and neck are much more frequent and have an excellent prognosis. For this reason, it is necessary to recognize the warning signs and symptoms and understand when to refer the patient to a reference center for the treatment of these pathologies. The clinical presentation of both benign and malignant lesions in children may be similar as usually, both categories have compressive effects. This confirms the fact that the clinical diagnosis is not sufficient and always requires instrumental investigations and biopsies. In this narrative review, we analyzed both malignant lesions such as lymphoma, rhabdomyosarcoma, thyroid tumors, salivary gland tumors, neuroblastoma, and nasopharyngeal carcinoma, and benign ones such as cystic dermoid teratoma, hemangioma, juvenile angiofibroma and fibrosis dysplasia. Indeed, we set out to discuss the most common lesions of this site by evaluating their characteristics to highlight the differentiation of malignant tumors from benign lesions and their correct clinical-therapeutic management. A literature search was carried out in the PubMed and Google Scholar databases to identify all narrative reviews addressing malignant and benign head and neck tumors of the pediatric age. In conclusion, the care of children affected by head and neck benign lesions and malignancy must be combined and multidisciplinary. It is essential to recognize the diseases early in order to differentiate and intervene as soon as possible for the correct clinical-therapeutic management.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963258575231123043807
2024-01-16
2024-12-24
Loading full text...

Full text loading...

References

  1. ChadhaN.K. ForteV. Pediatric head and neck malignancies.Curr. Opin. Otolaryngol. Head Neck Surg.200917647147610.1097/MOO.0b013e328332389319745735
    [Google Scholar]
  2. Lilja-FischerJ.K. SchrøderH. NielsenV.E. Pediatric malignancies presenting in the head and neck.Int. J. Pediatr. Otorhinolaryngol.2019118364110.1016/j.ijporl.2018.12.00930578994
    [Google Scholar]
  3. AhrensbergJ.M. OlesenF. HansenR.P. SchrøderH. VedstedP. Childhood cancer and factors related to prolonged diagnostic intervals: A Danish population-based study.Br. J. Cancer201310861280128710.1038/bjc.2013.8823449354
    [Google Scholar]
  4. AhrensbergJ.M. HansenR.P. OlesenF. SchrøderH. VedstedP. Presenting symptoms of children with cancer: A primary-care population-based study.Br. J. Gen. Pract.201262600e458e46510.3399/bjgp12X65231922781993
    [Google Scholar]
  5. DommettR.M. RedanielT. StevensM.C.G. MartinR.M. HamiltonW. Risk of childhood cancer with symptoms in primary care: A population-based case-control study.Br. J. Gen. Pract.201363606e22e2910.3399/bjgp13X66074223336454
    [Google Scholar]
  6. SchwartzI HughesC BriggerMT Pediatric head and neck malignancies: Incidence and trends, 1973-2010.Otolaryngol - Head Neck Surg20151521127113210.1177/0194599815575714
    [Google Scholar]
  7. RuttA.L. HawkshawM.J. LurieD. SataloffR.T. Salivary gland cancer in patients younger than 30 years.Ear Nose Throat J.201190417418410.1177/01455613110900040921500170
    [Google Scholar]
  8. DinauerC. FrancisG.L. Thyroid cancer in children.Endocrinol. Metab. Clin. North Am.2007363779806, vii10.1016/j.ecl.2007.04.00217673128
    [Google Scholar]
  9. IngleyK.M. Cohen-GogoS. GuptaA.A. Systemic therapy in pediatric-type soft-tissue sarcoma.Curr. Oncol.2020271161610.3747/co.27.548132174753
    [Google Scholar]
  10. MarcusK.J. TishlerR.B. Head and neck carcinomas across the age spectrum: Epidemiology, therapy, and late effects.Semin. Radiat. Oncol.2010201525710.1016/j.semradonc.2009.09.00419959031
    [Google Scholar]
  11. QaisiM. EidI. Pediatric head and neck malignancies.Oral Maxillofac. Surg. Clin. North Am.2016281111910.1016/j.coms.2015.07.00826614697
    [Google Scholar]
  12. BaroneE. HeadE. ButterfieldD.A. PerluigiM. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.Free Radic. Biol. Med.201711126226910.1016/j.freeradbiomed.2016.10.50827838436
    [Google Scholar]
  13. HaddadM. TrigliaJ.M. HelardotP. CouanetD. GauthierF. NeuenschwanderS. BourlièreB. BergeronC. MunzerC. RubieH. GuysJ.M. Localized cervical neuroblastoma: Prevention of surgical complications.Int. J. Pediatr. Otorhinolaryngol.200367121361136710.1016/j.ijporl.2003.08.04614643482
    [Google Scholar]
  14. DziubaI. KurzawaP. DopierałaM. LarqueA.B. Januszkiewicz-LewandowskaD. Rhabdomyosarcoma in children – current pathologic and molecular classification.Pol. J. Pathol.2018691203210.5114/pjp.2018.7533329895123
    [Google Scholar]
  15. LeviS. ZiniA. FischmanS. CzerninskiR. Epidemiology of oral, salivary gland and pharyngeal cancer in children and adolescents between 1970 and 2011.Oral Oncol.201767899410.1016/j.oraloncology.2017.02.01028351586
    [Google Scholar]
  16. ReM. TarchiniP. MacrìG. PasquiniE. Endonasal endoscopic approach for intracranial nasal dermoid sinus cysts in children.Int. J. Pediatr. Otorhinolaryngol.20127681217122210.1016/j.ijporl.2012.05.00422677464
    [Google Scholar]
  17. Pontes-MadrugaT.C. FilgueirasH.V.C. SilvaD.M.S. SilvaL.S. TestaJ.R.G. Fibrous dysplasia: Rare manifestation in the temporal bone.Rev. Bras. Otorrinolaringol.202288223524210.1016/j.bjorl.2020.05.02732800741
    [Google Scholar]
  18. ItinteangT. WithersA.H.J. DavisP.F. TanS.T. Biology of infantile hemangioma.Front. Surg.201413810.3389/fsurg.2014.0003825593962
    [Google Scholar]
  19. GuptaD.P. GuptaS. ShreevidyaS.R. Endoscopic modified denker’s approach for the treatment of juvenile nasopharyngeal angiofibroma.Indian J. Otolaryngol. Head Neck Surg.202074S292192810.1007/s12070‑020‑01984‑w36452834
    [Google Scholar]
  20. WakhluA. WakhluA.K. Head and neck teratomas in children.Pediatr. Surg. Int.2000165-633333710.1007/s00383000039110955557
    [Google Scholar]
  21. Head and Neck Cancers2021Available from: https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet
  22. AupérinA. Epidemiology of head and neck cancers: an update.Curr. Opin. Oncol.202032317818610.1097/CCO.000000000000062932209823
    [Google Scholar]
  23. VigneswaranN. WilliamsM.D. Epidemiologic trends in head and neck cancer and aids in diagnosis.Oral Maxillofac. Surg. Clin. North Am.201426212314110.1016/j.coms.2014.01.00124794262
    [Google Scholar]
  24. FioreM. MinniA. CavalcantiL. RaponiG. PuggioniG. MattiaA. GariglioS. ColizzaA. MelianteP.G. ZoccaliF. TaraniL. BarbatoC. LucarelliM. CeciF.M. FrancatiS. FerragutiG. CeccantiM. PetrellaC. The impact of alcohol consumption and oral microbiota on upper aerodigestive tract carcinomas: A pilot study.Antioxidants2023126123310.3390/antiox1206123337371963
    [Google Scholar]
  25. FioreM. TerracinaS. FerragutiG. PetrellaC. BrunoS.M. BlaconàG. Di CertoM.G. MinniA. GrecoA. MusacchioA. RalliM. TaraniL. CeccantiM. PolimeniA. TriacaV. Characteristic hallmarks of aging and the impact on carcinogenesis.Curr. Cancer Drug Targets20232328710210.2174/156800962266622081612035335975845
    [Google Scholar]
  26. MelianteP.G. ZoccaliF. de VincentiisM. RalliM. PetrellaC. FioreM. MinniA. BarbatoC. Diagnostic predictors of immunotherapy response in head and neck squamous cell carcinoma.Diagnostics202313586210.3390/diagnostics1305086236900006
    [Google Scholar]
  27. FerragutiG. TerracinaS. PetrellaC. GrecoA. MinniA. LucarelliM. AgostinelliE. RalliM. de VincentiisM. RaponiG. PolimeniA. CeccantiM. CarontiB. Di CertoM.G. BarbatoC. MattiaA. TaraniL. FioreM. Alcohol and head and neck cancer: Updates on the role of oxidative stress, genetic, epigenetics, oral microbiota, antioxidants, and alkylating agents.Antioxidants202211114510.3390/antiox1101014535052649
    [Google Scholar]
  28. RalliM. GrassoM. GilardiA. CeccantiM. MessinaM.P. TirassaP. FioreM. AltissimiG. A SalzanoF. De VincentiisM. GrecoA. The role of cytokines in head and neck squamous cell carcinoma: A review.Clin. Ter.20201713e268e27410.7417/CT.2020.222532323717
    [Google Scholar]
  29. MelianteP.G. BarbatoC. ZoccaliF. RalliM. GrecoA. de VincentiisM. ColizzaA. PetrellaC. FerragutiG. MinniA. FioreM. Programmed cell death-ligand 1 in head and neck squamous cell carcinoma: Molecular insights, preclinical and clinical data, and therapies.Int. J. Mol. Sci.202223231538410.3390/ijms23231538436499710
    [Google Scholar]
  30. RiccardiG. BellizziM.G. FatuzzoI. ZoccaliF. CavalcantiL. GrecoA. VincentiisM. RalliM. FioreM. PetrellaC. MinniA. BarbatoC. Salivary biomarkers in oral squamous cell carcinoma: A proteomic overview.Proteomes20221043710.3390/proteomes1004003736412636
    [Google Scholar]
  31. BovaR. Head and neck cancer.Med. Today201415273710.1177/1755738018758495
    [Google Scholar]
  32. LloydC. McHughK. The role of radiology in head and neck tumours in children.Cancer Imaging2010101496110.1102/1470‑7330.2010.000320199940
    [Google Scholar]
  33. AlbrightJ.T. TophamA.K. ReillyJ.S. KrausD.H. Pediatric head and neck malignancies: US incidence and trends over 2 decades.Arch. Otolaryngol. Head Neck Surg.2002128665565910.1001/archotol.128.6.65512049559
    [Google Scholar]
  34. RohJ.L. HuhJ. MoonH.N. Lymphomas of the head and neck in the pediatric population.Int. J. Pediatr. Otorhinolaryngol.20077191471147710.1016/j.ijporl.2007.06.00417624446
    [Google Scholar]
  35. ArboledaL.P.A. de MendonçaR.M.H. LopezE.E.M. AraújoA.L.D. PalmierN.R. de Pauli PaglioniM. FonsecaJ.M. HoffmannI.L. CardinalliI.A. ChavesA.L.F. ArandaS. BrandãoT.B. LopesM.A. RibeiroA.C.P. TroconisC.C.M. Santos-SilvaA.R. Global frequency and distribution of head and neck cancer in pediatrics, a systematic review.Crit. Rev. Oncol. Hematol.202014810289210.1016/j.critrevonc.2020.10289232120328
    [Google Scholar]
  36. ArboledaL.P.A. HoffmannI.L. CardinalliI.A. Santos-SilvaA.R. de MendonçaR.M.H. Demographic and clinicopathologic distribution of head and neck malignant tumors in pediatric patients from a Brazilian population: A retrospective study.J. Oral Pathol. Med.201847769670510.1111/jop.1272429729040
    [Google Scholar]
  37. ChakravartiA. ShashidharT.B. NaglotS. SahniJ.K. Head and neck teratomas in children: A case series.Indian J. Otolaryngol. Head Neck Surg.201163219319710.1007/s12070‑011‑0224‑822468260
    [Google Scholar]
  38. SenguptaS. PalR. SahaS. BeraS.P. PalI. TuliI. Spectrum of head and neck cancer in children.J. Indian Assoc. Pediatr. Surg.200914420020310.4103/0971‑9261.5960120419020
    [Google Scholar]
  39. IsraelA.T. AkangE.E.U. AkinyeleA.O. Paediatric head and neck cancers in Nigeria: Implications for treatment planning in resource limited settings.Niger. Med. J.201253424524810.4103/0300‑1652.10760423661887
    [Google Scholar]
  40. GosepathJ. SpixC. TaleblooB. BlettnerM. MannW.J. Incidence of childhood cancer of the head and neck in Germany.Ann. Oncol.200718101716172110.1093/annonc/mdm27817660492
    [Google Scholar]
  41. GrønhøjC. HjalgrimL. JakobsenK.K. CharabiB. MirianC. LaierG.H. KissK. RechnitzerC. FriborgJ. von BuchwaldC. HjulerT. Incidence of head and neck cancer in children: A Danish nationwide study from 1978 to 2014.Pediatr. Blood Cancer2018657e2703710.1002/pbc.2703729603576
    [Google Scholar]
  42. RapidisA.D. EconomidisJ. GoumasP.D. LangdonJ.D. SkordalakisA. TzortzatouF. AnagnostopoulosD. MatsaniotisN. Tumours of the head and neck in children.J. Craniomaxillofac. Surg.198816627928610.1016/S1010‑5182(88)80062‑33049677
    [Google Scholar]
  43. AbdulaiA.E. NuamahI.K. GyasiR. Head and neck tumours in Ghanaian children. A 20 year review.Int. J. Oral Maxillofac. Surg.201241111378138210.1016/j.ijom.2012.06.00422771221
    [Google Scholar]
  44. Al YamaniA.O. Al SebaeiM.O. BassyoniL.J. BadghaishA.J. ShawlyH.H. Variation of pediatric and adolescents head and neck pathology in the city of Jeddah: A retrospective analysis over 10 years.Saudi Dent. J.201123419720010.1016/j.sdentj.2011.09.00223960516
    [Google Scholar]
  45. KhademiB. TaraghiA. MohammadianpanahM. Anatomical and histopathological profile of head and neck neoplasms in Persian pediatric and adolescent population.Int. J. Pediatr. Otorhinolaryngol.20097391249125310.1016/j.ijporl.2009.05.01719525017
    [Google Scholar]
  46. de MeloA.U.C. ValenteR.O de H. MartorelliS.B de F. RibeiroC.F. da RosaM.R.D. Prevalence of malignant tumors of the head and neck region in infant and juvenile patients.Pesqui. Bras. Odontopediatria Clin. Integr.20101010.4034/1519.0501.2010.0103.0025
    [Google Scholar]
  47. BuhtoiarovI.N. Pediatric Lymphoma.Pediatr. Rev.201738941042310.1542/pir.2016‑015228864732
    [Google Scholar]
  48. PastoreG. MagnaniC. VerdecchiaA. PessionA. ViscomiS. CoeberghJ.W.W. Survival of childhood lymphomas in Europe, 1978–1992.Eur. J. Cancer200137670371010.1016/S0959‑8049(01)00002‑811311644
    [Google Scholar]
  49. WeberA.L. RahemtullahA. FerryJ.A. Hodgkin and non-Hodgkin lymphoma of the head and neck.Neuroimaging Clin. N. Am.200313337139210.1016/S1052‑5149(03)00039‑X14631680
    [Google Scholar]
  50. BispoJ.A.B. PinheiroP.S. KobetzE.K. Epidemiology and etiology of leukemia and lymphoma.Cold Spring Harb. Perspect. Med.2020106a03481910.1101/cshperspect.a03481931727680
    [Google Scholar]
  51. RenziS. Langenberg-VervergaertK.P.S. WaespeN. AliS. BartramJ. MichaeliO. UptonJ. CadaM. Primary immunodeficiencies and their associated risk of malignancies in children: an overview.Eur. J. Pediatr.2020179568969710.1007/s00431‑020‑03619‑232162064
    [Google Scholar]
  52. LambertM.P. ArulselvanA. SchottA. MarkhamS.J. CrowleyT.B. ZackaiE.H. McDonald-McGinnD.M. The 22q11.2 deletion syndrome: Cancer predisposition, platelet abnormalities and cytopenias.Am. J. Med. Genet. A.2018176102121212710.1002/ajmg.a.3847428940864
    [Google Scholar]
  53. MenghiM. MicangeliG. TaraniF. PutottoC. PirroF. MarianiA. PetrellaC. PulvirentiF. CinicolaB. ColloridiF. TaraniL. FioreM. Neuroinflammation and oxidative stress in individuals affected by digeorge syndrome.Int. J. Mol. Sci.2023244424210.3390/ijms2404424236835652
    [Google Scholar]
  54. Mauz-KörholzC. MetzgerM.L. KellyK.M. SchwartzC.L. CastellanosM.E. DieckmannK. KlugeR. KörholzD. Pediatric hodgkin lymphoma.J. Clin. Oncol.201533272975298510.1200/JCO.2014.59.485326304892
    [Google Scholar]
  55. CotmanC. HeadE. MuggenburgB. ZickerS. MilgramN. Brain aging in the canine: A diet enriched in antioxidants reduces cognitive dysfunction.Neurobiol. Aging200223580981810.1016/S0197‑4580(02)00073‑812392784
    [Google Scholar]
  56. ShanbhagS. AmbinderR.F. Hodgkin lymphoma: A review and update on recent progress.CA Cancer J. Clin.201868211613210.3322/caac.2143829194581
    [Google Scholar]
  57. HarrisN.L. JaffeE.S. SteinH. BanksP.M. ChanJ.K. ClearyM.L. DelsolG. De Wolf- PeetersC. FaliniB. GatterK.C. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group.Blood19948451361139210.1182/blood.V84.5.1361.13618068936
    [Google Scholar]
  58. SmithR.S. ChenQ. HudsonM.M. LinkM.P. KunL. WeinsteinH. BillettA. MarcusK.J. TarbellN.J. DonaldsonS.S. Prognostic factors for children with Hodgkin’s disease treated with combined-modality therapy.J. Clin. Oncol.200321102026203310.1200/JCO.2003.07.12412743158
    [Google Scholar]
  59. AppelB.E. ChenL. BuxtonA.B. HutchisonR.E. HodgsonD.C. EhrlichP.F. ConstineL.S. SchwartzC.L. Minimal treatment of low-risk, pediatric lymphocyte-predominant hodgkin lymphoma: A report from the children’s oncology group.J. Clin. Oncol.201634202372237910.1200/JCO.2015.65.346927185849
    [Google Scholar]
  60. BleyerA. O’LearyM. BarrR. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000.National Cancer InstituteBethesda, MD2006
    [Google Scholar]
  61. SandlundJ.T. DowningJ.R. CristW.M. Non-Hodgkin’s lymphoma in childhood.N. Engl. J. Med.1996334191238124810.1056/NEJM1996050933419068606720
    [Google Scholar]
  62. SandlundJ.T. Non-hodgkin lymphoma in children.Curr. Hematol. Malig. Rep.201510323724310.1007/s11899‑015‑0277‑y26174528
    [Google Scholar]
  63. RalliM. AngelettiD. D’AguannoV. CampoF. FioreM. GrecoA. de VincentiisM. Evaluation of surgical and functional outcomes of supracricoid laryngectomy and rehabilitation protocols.Clin. Ter.2021172436336810.7417/CT.2021.234134247220
    [Google Scholar]
  64. SandlundJ.T. MartinM.G. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.Hematology (Am. Soc. Hematol. Educ. Program)20162016158959710.1182/asheducation‑2016.1.58927913533
    [Google Scholar]
  65. CairoM.S. BeishuizenA. Childhood, adolescent and young adult non-Hodgkin lymphoma: Current perspectives.Br. J. Haematol.201918561021104210.1111/bjh.1576430729513
    [Google Scholar]
  66. PintoA. HutchisonR.E. GrantL.H. TrevenenC.L. BerardC.W. Follicular lymphomas in pediatric patients.Mod. Pathol.1990333083132194214
    [Google Scholar]
  67. LiF.P. FraumeniJ.F.Jr Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome.J. Natl. Cancer Inst.19694361365137310.1093/jnci/43.6.13655396222
    [Google Scholar]
  68. DislerR.T. GallagherR.D. DavidsonP.M. SunS-W. ChenL-C. ZhouM. Factors impairing the postural balance in COPD patients and its influence upon activities of daily living.Eur. Respir. J.201915
    [Google Scholar]
  69. RadzikowskaJ. KukwaW. KukwaA. CzarneckaA. KrzeskiA. Review Rhabdomyosarcoma of the head and neck in children.Contemp. Oncol.2015229810710.5114/wo.2015.4915826034386
    [Google Scholar]
  70. RodriguezK.D. SchneiderK.W. SuttmanA. GarringtonT. JellinsT. TholenK. FrancomC.R. HerrmannB.W. Pediatric head and neck tumors associated with li-fraumeni syndrome.Ann. Otol. Rhinol. Laryngol.2022131215916310.1177/0003489421101478633971750
    [Google Scholar]
  71. CöktüS. SpixC. KaiserM. BeygoJ. KleinleS. BachmannN. KohlschmidtN. PrawittD. BeckmannA. KlaesR. Nevinny-Stickel-HinzpeterC. DöhnertS. KrausC. KadgienG. VaterI. BiskupS. KutscheM. KohlhaseJ. EggermannT. ZenkerM. KratzC.P. Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: A retrospective cohort study.Br. J. Cancer2020123461962310.1038/s41416‑020‑0911‑x32451468
    [Google Scholar]
  72. TaraniL. RasioD. TaraniF. ParlapianoG. ValentiniD. DylagK.A. SpaliceA. PaparellaR. FioreM. Pediatrics for disability: A comprehensive approach to children with syndromic psychomotor delay.Curr. Pediatr. Rev.202218211012010.2174/157339631766621112909342634844545
    [Google Scholar]
  73. WalterhouseD. WatsonA. Optimal management strategies for rhabdomyosarcoma in children.Paediatr. Drugs20079639140010.2165/00148581‑200709060‑0000618052409
    [Google Scholar]
  74. ParhamD.M. EllisonD.A. Rhabdomyosarcomas in adults and children: An update.Arch. Pathol. Lab. Med.2006130101454146510.5858/2006‑130‑1454‑RIAACA17090187
    [Google Scholar]
  75. QuayleF.J. MoleyJ.F. Medullary thyroid carcinoma: Including MEN 2A and MEN 2B syndromes.J. Surg. Oncol.200589312212910.1002/jso.2018415719378
    [Google Scholar]
  76. HaakH.R. CornelisseC.J. GoslingsB.M. FleurenG.J. Nuclear DNA content of medullary thyroid carcinoma in a large family with the MEN-2A syndrome.J. Endocrinol. Invest.199114426126410.1007/BF033468081677951
    [Google Scholar]
  77. PaparellaR. MenghiM. MicangeliG. LeonardiL. ProfetaG. TaraniF. PetrellaC. FerragutiG. FioreM. TaraniL. Autoimmune polyendocrine syndromes in the pediatric age.Children202310358810.3390/children1003058836980146
    [Google Scholar]
  78. Gómez IG.C. PonceM.J.L. BeldaI.T. BoscàR.A. SebastianP.C. NavarroM.R. CaballeroS.M. MeseguerA.M. The optimal age for performing surgery on patients with MEN 2B syndrome.Oncol. Lett.20112592993010.3892/ol.2011.33222866152
    [Google Scholar]
  79. AgarwalA. Lugo-VicenteH. Thyroid cancer in children.Bol. Asoc. Med. P. R.2009106319110.5005/jp/books/10258_2925470911
    [Google Scholar]
  80. Al NofalA. GionfriddoM.R. JavedA. HaydourQ. BritoJ.P. ProkopL.J. PittockS.T. MuradM.H. Accuracy of thyroid nodule sonography for the detection of thyroid cancer in children: Systematic review and meta-analysis.Clin. Endocrinol.201684342343010.1111/cen.1278625845503
    [Google Scholar]
  81. FerragutiG. TerracinaS. MicangeliG. LucarelliM. TaraniL. CeccantiM. SpazianiM. D’OraziV. PetrellaC. FioreM. NGF and BDNF in pediatrics syndromes.Neurosci. Biobehav. Rev.202314510501510.1016/j.neubiorev.2022.10501536563920
    [Google Scholar]
  82. TaraniL. MicangeliG. RasioD. OttombrinoS. LiberatiN. De AngelisD. CaritoV. GrecoA. CeccantiM. FioreM. Clinical and genetic approach to the dysmorphic child.Biomedical Reviews2018290374610.14748/bmr.v29.5848
    [Google Scholar]
  83. RivkeesS.A. MazzaferriE.L. VerburgF.A. ReinersC. LusterM. BreuerC.K. DinauerC.A. UdelsmanR. The treatment of differentiated thyroid cancer in children: Emphasis on surgical approach and radioactive iodine therapy.Endocr. Rev.201132679882610.1210/er.2011‑001121880704
    [Google Scholar]
  84. HallwirthU. FloresJ. KasererK. NiederleB. Differentiated thyroid cancer in children and adolescents: The importance of adequate surgery and review of literature.Eur. J. Pediatr. Surg.19999635936310.1055/s‑2008‑107228310661843
    [Google Scholar]
  85. LocatiL.D. ColliniP. ImbimboM. BarisellaM. TestiA. LicitraL.F. LöningT. TiemannK. QuattroneP. BimbattiE. ChiaravalliS. CasanovaM. TamboriniE. CartaR. GaspariniP. GuzzoM. MassiminoM. FerrariA. Immunohistochemical and molecular profile of salivary gland cancer in children.Pediatr. Blood Cancer2017649e2646810.1002/pbc.2646828139061
    [Google Scholar]
  86. ZamaniM. GrønhøjC. Schmidt JensenJ. von BuchwaldC. CharabiB.W. HjulerT. Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta-analysis.Pediatr. Blood Cancer2019663e2754310.1002/pbc.2754330378272
    [Google Scholar]
  87. CasanovaM. BisognoG. GandolaL. CecchettoG. Di CataldoA. BassoE. IndolfiP. D’AngeloP. FaviniF. ColliniP. PotepanP. FerrariA. A prospective protocol for nasopharyngeal carcinoma in children and adolescents.Cancer2012118102718272510.1002/cncr.2652821918965
    [Google Scholar]
  88. BaristaI. VaranA. OzyarE. Bimodal age distribution in Hodgkin’s disease and nasopharyngeal carcinoma.Med. Hypotheses2007686142110.1016/j.mehy.2006.11.01417196754
    [Google Scholar]
  89. AyanI. KaytanE. AyanN. Childhood nasopharyngeal carcinoma: From biology to treatment.Lancet Oncol.200341132110.1016/S1470‑2045(03)00956‑212517535
    [Google Scholar]
  90. YoungL.S. DawsonC.W. Epstein-Barr virus and nasopharyngeal carcinoma.Chin. J. Cancer2014331210.5732/cjc.014.1019725418193
    [Google Scholar]
  91. HuangW.B. ChanJ.Y.W. LiuD.L. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.Cancer2018124353053610.1002/cncr.3103129072774
    [Google Scholar]
  92. LohK.S. GohB.C. LuJ. HsiehW.S. TanL. Familial nasopharyngeal carcinoma in a cohort of 200 patients.Arch. Otolaryngol. Head Neck Surg.20061321828510.1001/archotol.132.1.8216415435
    [Google Scholar]
  93. UngA. ChenC.J. LevineP.H. ChengY.J. BrintonL.A. ChenI.H. GoldsteinA.M. HsuM.M. ChhabraS.K. ChenJ.Y. AppleR.J. YangC.S. HildesheimA. Familial and sporadic cases of nasopharyngeal carcinoma in Taiwan.Anticancer Res.1999191B66166510216473
    [Google Scholar]
  94. Ayanİ. AltunM. Nasopharyngeal carcinoma in children: Retrospective review of 50 patients.Int. J. Radiat. Oncol. Biol. Phys.199635348549210.1016/S0360‑3016(96)80010‑18655371
    [Google Scholar]
  95. DourtheM.E. BolleS. TemamS. JouinA. ClaudeL. ReguerreY. DefachellesA.S. OrbachD. FresneauB. Childhood nasopharyngeal carcinoma: State-of-the-art, and questions for the future.J. Pediatr. Hematol. Oncol.2018402859210.1097/MPH.000000000000105429300240
    [Google Scholar]
  96. MertensR. GranzenB. LassayL. BucskyP. HundgenM. StetterG. HeimannG. WeissC. HessC.F. GademannG. Treatment of nasopharyngeal carcinoma in children and adolescents.Cancer200510451083108910.1002/cncr.2125815999363
    [Google Scholar]
  97. Ben-AmiT. KontnyU. SurunA. BrechtI.B. AlmarazR.L. DragomirM. PourtsidisA. CasanovaM. FresneauB. BisognoG. SchneiderD.T. ReguerreY. BienE. Stachowicz-StencelT. ÖsterlundhG. WygodaM. JanssensG.O. ZsirosJ. JehannoN. BrisseH.J. GandolaL. ChristiansenH. ClaudeL. FerrariA. Rodriguez-GalindoC. OrbachD. Nasopharyngeal carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations.Pediatr. Blood Cancer202168S4e2901810.1002/pbc.2901833844410
    [Google Scholar]
  98. HasnaouiM. LahmarR. Ben MabroukA. MasmoudiM. MighriK. DrissN. Predictive epidemiological and clinical factors of nasopharyngeal carcinoma diagnosis: Adult versus pediatric population.Int. J. Pediatr. Otorhinolaryngol.202013711020310.1016/j.ijporl.2020.11020332658801
    [Google Scholar]
  99. BowenK.A. ChungD.H. Recent advances in neuroblastoma.Curr. Opin. Pediatr.200921335035610.1097/MOP.0b013e32832b124019381091
    [Google Scholar]
  100. ConcesM.R. Peripheral neuroblastic tumors of the adrenal gland: Clinicopathologic features and important molecular alterations.Diagn. Histopathol.202026520020610.1016/j.mpdhp.2020.02.002
    [Google Scholar]
  101. CohnS.L. PearsonA.D.J. LondonW.B. MonclairT. AmbrosP.F. BrodeurG.M. FaldumA. HeroB. IeharaT. MachinD. MosseriV. SimonT. GaraventaA. CastelV. MatthayK.K. The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report.J. Clin. Oncol.200927228929710.1200/JCO.2008.16.678519047291
    [Google Scholar]
  102. de KrakerJ. HoefnagelK.A. VerschuurA.C. van EckB. van SantenH.M. CaronH.N. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.Eur. J. Cancer200844455155610.1016/j.ejca.2008.01.01018267358
    [Google Scholar]
  103. KawaguchiA. KunimotoK. InabaY. MikitaN. KaminakaC. KanazawaN. YamamotoY. KakimotoN. SuenagaT. TakeuchiT. SuzukiH. BabaN. JinninM. Distribution analysis of infantile hemangioma or capillary malformation on the head and face in Japanese patients.J. Dermatol.2019461084985210.1111/1346‑8138.1505131418467
    [Google Scholar]
  104. DingY. ZhangJ.Z. YuS.R. XiangF. KangX.J. Risk factors for infantile hemangioma: A meta-analysis.World J. Pediatr.202016437738410.1007/s12519‑019‑00327‑231853885
    [Google Scholar]
  105. WangC. LiY. XiangB. XiongF. LiK. YangK. ChenS. JiY. Quality of life in children with infantile hemangioma: A case control study.Health Qual. Life Outcomes201715122110.1186/s12955‑017‑0772‑z29145889
    [Google Scholar]
  106. QiuT. YangK. DaiS. ChenS. JiY. Clinical features of segmental infantile hemangioma: A prospective study.Ther. Clin. Risk Manag.20211711912510.2147/TCRM.S29105933536759
    [Google Scholar]
  107. BhatV. SalinsP.C. BhatV. Imaging spectrum of hemangioma and vascular malformations of the head and neck in children and adolescents.J. Clin. Imaging Sci.201443110.4103/2156‑7514.13517925161800
    [Google Scholar]
  108. KumJ.J.Y. KhanZ.A. Mechanisms of propranolol action in infantile hemangioma.Dermatoendocrinol201461e97969910.4161/19381980.2014.97969926413184
    [Google Scholar]
  109. SmithsonS.L. RademakerM. AdamsS. BadeS. BekhorP. DavidsonS. DoreA. DrummondC. FischerG. GinA. GrillsC. HalbertA. LokmicZ. McCahonE. MorganV.A. MurrellD.F. OrchardD. PeningtonA. PurvisD. RelicJ. RobertsonS. RobinsonA.J. ScardamagliaL. SuJ. TanS. WargonO. WarrenL. WongL. ZappalaT. PhillipsR. Consensus statement for the treatment of infantile haemangiomas with propranolol.Australas. J. Dermatol.201758215515910.1111/ajd.1260028251611
    [Google Scholar]
  110. KadlubN. ToumaJ. LeboulangerN. GarelC. SoupreV. L’HerminéA.C. VazquezM.P. PicardA. Head and neck teratoma: From diagnosis to treatment.J. Craniomaxillofac. Surg.20144281598160310.1016/j.jcms.2014.04.02824954765
    [Google Scholar]
  111. ProfetaG. MicangeliG. TaraniF. PaparellaR. FerragutiG. SpazianiM. IsidoriA.M. MenghiM. CeccantiM. FioreM. TaraniL. Sexual developmental disorders in pediatrics.Clin. Ter.2022173547548810.7417/CT.2022.246636155734
    [Google Scholar]
  112. BrodskyJ.R. IraceA.L. DidasA. WattersK. EstroffJ.A. BarnewoltC.E. Perez-AtaydeA. RahbarR. Teratoma of the neonatal head and neck: A 41-year experience.Int. J. Pediatr. Otorhinolaryngol.201797667110.1016/j.ijporl.2017.02.01128483254
    [Google Scholar]
  113. KumarS.Y. ShrikrishnaU. ShettyJ. SitaramA. Epignathus with fetiform features.J. Lab. Physicians20113105605810.4103/0974‑2727.7857121701667
    [Google Scholar]
  114. JadhavS.S. KordayC.S. MalikS. ShahV.K. LadS.K. Epignathus leading to fatal airway obstruction in a neonate.J. Clin. Diagn. Res.2017111SD04SD0510.7860/JCDR/2017/24956.928328274016
    [Google Scholar]
  115. TsitouridisI. SidiropoulosD. MichaelidesM. Sonographic evaluation of epignathus.Hippokratia2009131555719240824
    [Google Scholar]
  116. SariogluN. WegnerR.D. Gasiorek-WiensA. EntezamiM. SchmockJ. HagenA. BeckerR. Epignathus: Always a simple teratoma? Report of an exceptional case with two additional fetiforme bodies.Ultrasound Obstet. Gynecol.200321439740310.1002/uog.9212704752
    [Google Scholar]
  117. AlexanderV.R.C. ManjalyJ.G. PepperC.M. IfeachoS.N. HewittR.J. HartleyB.E.J. Head and neck teratomas in children—A series of 23 cases at Great Ormond Street Hospital.Int. J. Pediatr. Otorhinolaryngol.201579122008201410.1016/j.ijporl.2015.07.04226611341
    [Google Scholar]
  118. LaoW.P. LagabonK.J. AromG.A. WalkerP.C. LeeS.C. Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.Head Neck202143271972410.1002/hed.2651633111428
    [Google Scholar]
  119. RalliM. FusconiM. ViscontiI. MartellucciS. de VincentiisM. GrecoA. Nasopharyngeal angiofibroma in an elderly female patient: A rare case report.Mol. Clin. Oncol.20189670270410.3892/mco.2018.173530546905
    [Google Scholar]
  120. SuroyoI. BudiantoT. The role of diagnostic and interventional radiology in juvenile nasopharyngeal angiofibroma: A case report and literature review.Radiol. Case Rep.202015781281510.1016/j.radcr.2020.04.01732346460
    [Google Scholar]
  121. UetzS. CrosbyD.L. Current management of juvenile nasopharyngeal angiofibroma.Curr. Treat. Options Allergy20207333534610.1007/s40521‑020‑00265‑9
    [Google Scholar]
  122. MarodaA.J. BeckmannN.A. SheynA.M. ElijovichL. MichaelL.M. DiNittoJ.M. RangarajanS.V. Trimodal embolization of juvenile nasopharyngeal angiofibroma with intracranial extension.Int. J. Pediatr. Otorhinolaryngol.202013010980510.1016/j.ijporl.2019.10980531864085
    [Google Scholar]
  123. ChoiJ.S. YuJ. LovinB.D. ChapelA.C. PatelA.J. GallagherK.K. Effects of preoperative embolization on juvenile nasopharyngeal angiofibroma surgical outcomes: A study of the kids’ inpatient database.J. Neurol. Surg. B Skull Base202283107608110.1055/s‑0040‑171667635155073
    [Google Scholar]
  124. LópezF. TriantafyllouA. SnydermanC.H. HuntJ.L. SuárezC. LundV.J. StrojanP. SabaN.F. NixonI.J. DevaneyK.O. AlobidI. Bernal-SprekelsenM. HannaE.Y. RinaldoA. FerlitoA. Nasal juvenile angiofibroma: Current perspectives with emphasis on management.Head Neck20173951033104510.1002/hed.2469628199045
    [Google Scholar]
  125. MakhdoomN. Abo El EzzT.A. Abdel-HaleemM. Management of midline nasal dermoid lesions in children by external rhinoplasty.J. Taibah Univ. Med. Sci.201712432432810.1016/j.jtumed.2017.02.00331435258
    [Google Scholar]
  126. PollardZ.F. HarleyR.D. CalhounJ. Dermoid cysts in children.Pediatrics197657337938210.1542/peds.57.3.3791256948
    [Google Scholar]
  127. IndulkarS. HsichG.E. Spontaneous rupture of intracranial dermoid cyst in a child.Neurology20117723207010.1212/WNL.0b013e31823b479f22146923
    [Google Scholar]
  128. SatoH. ShibataM. ShimizuT. ShibataS. ToriumiH. EbineT. KuroiT. IwashitaT. FunakuboM. KayamaY. AkazawaC. WajimaK. NakagawaT. OkanoH. SuzukiN. Differential cellular localization of antioxidant enzymes in the trigeminal ganglion.Neuroscience201324834535810.1016/j.neuroscience.2013.06.01023774632
    [Google Scholar]
  129. WirthT. Fibröse Dysplasie.Orthopade2020491092994010.1007/s00132‑020‑03984‑832960303
    [Google Scholar]
  130. CouturierA. AumaîtreO. GilainL. JeanB. MomT. AndréM. Craniofacial fibrous dysplasia: A 10-case series.Eur. Ann. Otorhinolaryngol. Head Neck Dis.2017134422923510.1016/j.anorl.2017.02.00428302454
    [Google Scholar]
  131. RobinsonC. CollinsM.T. BoyceA.M. Fibrous dysplasia/mccune-albright syndrome: Clinical and translational perspectives.Curr. Osteoporos. Rep.201614517818610.1007/s11914‑016‑0317‑027492469
    [Google Scholar]
  132. PaiB. FerdinandD. Fibrous dysplasia causing safeguarding concerns.Arch. Dis. Child.20139812100310.1136/archdischild‑2013‑30449023966029
    [Google Scholar]
  133. DiCaprioM.R. EnnekingW.F. Fibrous dysplasia. Pathophysiology, evaluation, and treatment.J. Bone Joint Surg. Am.20058781848186410.2106/JBJS.D.0294216085630
    [Google Scholar]
  134. PaulS.M. GaborL.R. RudzinskiS. GiovanniD. BoyceA.M. KellyM.R.N. CollinsM.T. Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia.Bone201460414710.1016/j.bone.2013.11.02224316419
    [Google Scholar]
  135. LeetA.I. BoyceA.M. IbrahimK.A. WientroubS. KushnerH. CollinsM.T. Bone-grafting in polyostotic fibrous dysplasia.J. Bone Joint Surg. Am.201698321121910.2106/JBJS.O.0054726842411
    [Google Scholar]
  136. TanY.C. YuC.C. ChangC.N. MaL. ChenY.R. Optic nerve compression in craniofacial fibrous dysplasia: The role and indications for decompression.Plast. Reconstr. Surg.200712071957196210.1097/01.prs.0000287338.28018.c718090759
    [Google Scholar]
/content/journals/cpr/10.2174/0115733963258575231123043807
Loading
/content/journals/cpr/10.2174/0115733963258575231123043807
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): adolescent; children; Head and neck cancer; pediatric; surgery; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test